Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Injuries

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Injuries in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.

Research Excerpts

ExcerptRelevanceReference
"Dermal scarring and scar contracture result in restriction of movement."1.37Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase. ( Bergeron, A; Bond, JE; Kokosis, G; Levinson, H; Ren, L; Selim, MA, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bond, JE1
Kokosis, G1
Ren, L1
Selim, MA1
Bergeron, A1
Levinson, H1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Injuries

ArticleYear
Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase.
    Plastic and reconstructive surgery, 2011, Volume: 128, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Animals; Biopsy, Needle; Blotting, Western; Ci

2011